Conexeu Sciences Inc. (CNXU) Income Statement
CNXU FY2025 at a glance
Fiscal year ended October 31, 2025 · U.S. dollarsCNXU revenue and net income
CNXU growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CNXU quarterly EPS vs estimates
Conexeu Sciences beat the analyst EPS estimate in 0 of the last 1 quarters.
CNXU income statement
| FY2025 | FY2024 | |
|---|---|---|
| Revenue | $0 | $0 |
| Research & development | $478,169 | $280,081 |
| Sales, general & admin | $3.5M | $362,961 |
| Total operating expenses | $4.0M | $643,042 |
| Operating income | −$4.0M | −$643,042 |
| Interest income | $1,731 | $0 |
| Interest expense | $4,949 | $16,505 |
| Income before taxes | −$3.9M | −$471,867 |
| Net income | −$3.9M | −$471,867 |
| EBITDA | −$3.9M | −$455,362 |
| EPS (diluted) | −$0.19 | — |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $1.5M | $152,317 | $159,607 | $130,988 | $186,828 | $98,802 | $61,550 |
| Sales, general & admin | $5.8M | $2.2M | $1.5M | $1.8M | $1.1M | $353,702 | $270,608 |
| Total operating expenses | $7.7M | $2.4M | $1.7M | $1.9M | $1.3M | $456,055 | $332,721 |
| Operating income | −$7.7M | −$2.4M | −$1.7M | −$1.9M | −$1.3M | −$456,055 | −$332,721 |
| Interest income | $34,214 | $84,295 | $11,290 | $1,345 | $429 | $0 | $0 |
| Interest expense | $0 | $0 | $0 | $0 | — | $1,383 | $3,610 |
| Income before taxes | −$7.7M | −$2.3M | −$1.7M | −$1.9M | −$1.3M | −$458,050 | −$290,064 |
| Net income | −$7.7M | −$2.3M | −$1.7M | −$1.9M | −$1.3M | −$458,050 | −$290,064 |
| EBITDA | −$7.7M | −$2.3M | −$1.7M | −$1.9M | −$1.3M | — | — |
| EPS (diluted) | −$0.29 | −$0.09 | — | — | — | — | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CNXU's financial statements (latest annual report filed —); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CNXU financial results
Conexeu Sciences reported no revenue in fiscal year 2025 (ended October 31, 2025). It had a net loss of $3.9 million. Diluted earnings per share came to −$0.19.
See the CNXU stock overview for the latest quote and news, or the CNXU chart for price history and technical indicators.
CNXU income statement FAQ
Does Conexeu Sciences have revenue?
Conexeu Sciences reported no revenue for fiscal year 2025, which ended on October 31, 2025.
Is Conexeu Sciences profitable?
No. Conexeu Sciences reported a net loss of $3.9 million in fiscal 2025.
How much does Conexeu Sciences spend on research and development?
Conexeu Sciences spent $0.5 million on research and development in fiscal 2025.
What are Conexeu Sciences's earnings per share?
Conexeu Sciences earned $-0.19 per diluted share in fiscal 2025.
When does Conexeu Sciences's fiscal year end?
Conexeu Sciences's fiscal year ends in October. The latest annual report covers the year ended October 31, 2025.